Bank of America upgraded shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Free Report) from an underperform rating to a neutral rating in a report issued on Friday morning, Marketbeat reports.
Separately, The Goldman Sachs Group began coverage on shares of Bayer Aktiengesellschaft in a report on Thursday, May 30th. They issued a neutral rating on the stock. One equities research analyst has rated the stock with a sell rating and nine have issued a hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of Hold.
Get Our Latest Research Report on Bayer Aktiengesellschaft
Bayer Aktiengesellschaft Price Performance
Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.25 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.25. The company had revenue of $12 billion for the quarter. Bayer Aktiengesellschaft had a positive return on equity of 16.96% and a negative net margin of 2.74%. As a group, sell-side analysts forecast that Bayer Aktiengesellschaft will post 1.37 EPS for the current fiscal year.
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Featured Articles
- Five stocks we like better than Bayer Aktiengesellschaft
- Insider Buying Explained: What Investors Need to Know
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
- Stock Dividend Cuts Happen Are You Ready?
- Cloud Security Stocks Face Off: Find Out Who’s Leading the Market
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Defensive Sectors: Shielding Your Portfolio in Volatile Times
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.